会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 48. 发明申请
    • DEVICE AND METHOD FOR DETERMINING REACTION KINETICS
    • 用于确定反应动力学的装置和方法
    • US20160154004A1
    • 2016-06-02
    • US14942117
    • 2015-11-16
    • UNIVERSITY OF DELAWAREAMGEN
    • CHRISTOPHER J. ROBERTSGREGORY V. BARNETTVLADIMIR I. RAZINKOVBRUCE A. KERWIN
    • G01N33/68
    • G01N33/6845G01N33/50
    • A method of determining the activation energy Ea for degradation of a chemical species includes in sequence the steps of a) simultaneously incubating a plurality of samples of the chemical species in a single unitary device at a plurality of constant temperatures T, in each case for an incubation time t selected to result in loss of at most 20 mol % of the amount originally present; b) quenching each of the samples to stop degradation; c) determining the mole fraction m of the chemical species remaining in each of the quenched samples, relative to the amount present before incubating; d) determining for each sample a reaction rate coefficient kobs according to the equation k obs  ( T ) = 1 - m  ( T ) t ; and e) performing numerical regression of the kobs values obtained in step d) and the corresponding temperatures T in ° K to derive the activation energy Ea according to the following equation k obs = k 0  exp  ( E a R  ( 1 T - 1 T 0 ) ) , or to derive a temperature-dependent activation energy if that is more appropriate for the chemical species of interest.
    • 确定用于化学物质降解的活化能Ea的方法包括以下步骤:a)在多个恒定温度T下同时将多个化学物质样品在单个整体装置中孵育,在每种情况下为 孵育时间t被选择导致最初存在的量的至多20摩尔%的损失; b)淬灭每个样品以停止降解; c)确定每个淬火样品中剩余的化学物质相对于孵育前存在的量的摩尔分数m; d)根据等式k obs(T)= 1-m(T)t确定每个样本的反应速率系数kobs; 和e)对步骤d)中获得的科布值进行数值回归,并以相应的温度T(°K)进行数学回归,以根据以下等式得出活化能Ea(E a R(1 T - 1 T 0)),或者如果这更适合于感兴趣的化学物质,则导出温度依赖性的活化能。
    • 50. 发明申请
    • DETECTING AND QUANTIFYING CRYPTIC HIV REPLICATION
    • 检测和定量CRYPIC HIV复制
    • US20150024381A1
    • 2015-01-22
    • US14382568
    • 2013-03-07
    • UNIVERSITY OF DELAWARE
    • Ryan Zurakowski
    • G01N33/569
    • G01N33/56988C12Q1/703C12Q2600/136G01N2800/52
    • The present invention relates to a novel method for detecting efficient cryptic HIV replication in a patient who receives a suppressive antiviral therapy followed by administration of the HIV integrase inhibitor in an effective amount for intensifying the suppressive antiviral therapy, and has undetectable plasma viremia prior to the administration of the HIV integrase inhibitor. The method comprises making a pre-intensification measurement and one or more post-intensification measurements of the concentration of an episomal artifact in samples from the patient, and computing a pre-intensification HIV infection success ratio (R). A pre-intensification HIV infection success ratio (R) sufficiently close to 1 indicates that the patient has the efficient cryptic HIV replication. The method may further comprise quantifying the efficient cryptic HIV replication.
    • 本发明涉及一种用于在接受抑制性抗病毒治疗,然后以有效量施用HIV整合酶抑制剂的患者中检测有效的隐匿性HIV复制的新方法,用于增强抑制性抗病毒治疗,并且在治疗之前具有不可检测的血浆病毒血症 给予HIV整合酶抑制剂。 该方法包括对来自患者的样品中的附加型假象的浓度进行预强化测量和一次或多次强化后测量,以及计算强化前HIV感染成功率(R)。 强化前艾滋病毒感染成功率(R)足够接近1表示患者具有有效的隐匿性HIV复制。 该方法还可以包括量化有效的隐性HIV复制。